{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:58:21Z","timestamp":1793271501585,"version":"4.5.0"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,2,10]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate whether there is a window of opportunity for psoriatic arthritis (PsA) patients and to assess which patient characteristics are associated with a longer diagnostic delay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All newly diagnosed, disease-modifying antirheumatic drug-na\u00efve PsA patients who participated in the Dutch southwest Early PsA cohoRt and had \u22653 years of follow-up were studied. First, total delay was calculated as the time period between symptom onset and PsA diagnosis made by a rheumatologist and then split into patient and physician delays. The total delay was categorised into short (&lt;12 weeks), intermediate (12\u2009weeks to 1 year) or long (&gt;1 year). These groups were compared on clinical (Minimal Disease Activity (MDA) and Disease Activity index for PSoriatic Arthritis (DAPSA) remission) and patient-reported outcomes during 3 years follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>708 PsA patients were studied of whom 136 (19%), 237 (33%) and 335 (47%) had a short, intermediate and long total delay, respectively. Patient delay was 1.0\u2009month and physician delay was 4.5 months. Patients with a short delay were more likely to achieve MDA (OR 2.55, p=0.003) and DAPSA remission (OR 2.35,p=0.004) compared with PsA patients with a long delay. Patient-reported outcomes showed numerical but non-significant differences between the short and long delay groups. Female patients and those presenting with enthesitis, chronic back pain or normal C-reactive protein (CRP) had a longer delay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In PsA, referral and diagnosis within 1 year is associated with better clinical outcomes, suggesting the presence of a window of opportunity. The most gain in referral could be obtained in physician delay and in females, patients with enthesitis, chronic back pain or normal CRP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-004062","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T13:15:54Z","timestamp":1709039754000},"page":"e004062","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Window of opportunity in psoriatic arthritis: the earlier the better?"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-7777","authenticated-orcid":false,"given":"Selinde V J","family":"Snoeck Henkemans","sequence":"first","affiliation":[{"name":"Rheumatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-6222","authenticated-orcid":false,"given":"Pascal H P","family":"de Jong","sequence":"additional","affiliation":[{"name":"Rheumatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-7932","authenticated-orcid":false,"given":"Jolanda J","family":"Luime","sequence":"additional","affiliation":[{"name":"Rheumatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2394-6926","authenticated-orcid":false,"given":"Marc R","family":"Kok","sequence":"additional","affiliation":[{"name":"Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilja","family":"Tchetverikov","sequence":"additional","affiliation":[{"name":"Rheumatology, Albert Sweitzer Hospital, Dordrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy-Anne","family":"Korswagen","sequence":"additional","affiliation":[{"name":"Rheumatology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd M","family":"van der Kooij","sequence":"additional","affiliation":[{"name":"Rheumatology, Haga Hospital, Den Haag, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maikel","family":"van Oosterhout","sequence":"additional","affiliation":[{"name":"Rheumatology, Groene Hart Hospital, Gouda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Baudoin","sequence":"additional","affiliation":[{"name":"Rheumatology, Reumazorg Zuid West Nederland, Roosendaal, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bijsterbosch","sequence":"additional","affiliation":[{"name":"Rheumatology, Amphia Hospital, Breda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos H","family":"van der Kaap","sequence":"additional","affiliation":[{"name":"Rheumatology, Admiraal De Ruyter Hospital, Goes, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8572-1437","authenticated-orcid":false,"given":"Annette H M","family":"van der Helm-van Mil","sequence":"additional","affiliation":[{"name":"Rheumatology, Erasmus MC, Rotterdam, The Netherlands"},{"name":"Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn","family":"Vis","sequence":"additional","affiliation":[{"name":"Rheumatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"2025090312032273000_10.1.e004062.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.05.001"},{"key":"2025090312032273000_10.1.e004062.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204858"},{"key":"2025090312032273000_10.1.e004062.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202608"},{"key":"2025090312032273000_10.1.e004062.4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis (GRAPPA): updated treatment recommendations for Psoriatic arthritis 2021","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2025090312032273000_10.1.e004062.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.150938"},{"key":"2025090312032273000_10.1.e004062.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211734"},{"key":"2025090312032273000_10.1.e004062.7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/art.40391","article-title":"Group for research and assessment of psoriasis and Psoriatic arthritis\/outcome measures in rheumatology consensus\u2010based recommendations and research agenda for use of composite measures and treatment targets in psoriatic arthritis","volume":"70","author":"Coates","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2025090312032273000_10.1.e004062.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209511"},{"key":"2025090312032273000_10.1.e004062.9","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002706","article-title":"Importance of quick attainment of minimal disease activity for a positive impact on lives of patients with psoriatic arthritis","volume":"8","author":"Snoeck Henkemans","year":"2022","journal-title":"RMD Open"},{"key":"2025090312032273000_10.1.e004062.10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.semarthrit.2020.03.015","article-title":"Comparison of remission and low disease activity States with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study","volume":"50","author":"Coates","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"5 Suppl 31","key":"2025090312032273000_10.1.e004062.11","first-page":"S154","article-title":"Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention","volume":"21","author":"Quinn","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312032273000_10.1.e004062.12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh199"},{"key":"2025090312032273000_10.1.e004062.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.10135"},{"key":"2025090312032273000_10.1.e004062.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.27692"},{"key":"2025090312032273000_10.1.e004062.15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/03009742.2020.1803398","article-title":"Lessons learned from clinical phenotypes in early Psoriatic arthritis: the real-world Dutch South West early Psoriatic arthritis study","volume":"50","author":"Kasiem","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"2025090312032273000_10.1.e004062.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2012.05.005"},{"key":"2025090312032273000_10.1.e004062.17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1468-3083.2011.04138.x","article-title":"The diagnosis of early psoriatic arthritis in an outpatient dermatological centre for psoriasis","volume":"26","author":"Bonifati","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025090312032273000_10.1.e004062.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03753.x"},{"key":"2025090312032273000_10.1.e004062.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.23568"},{"key":"2025090312032273000_10.1.e004062.20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100857"},{"issue":"5 Suppl 39","key":"2025090312032273000_10.1.e004062.21","first-page":"S14","article-title":"The health assessment questionnaire (HAQ)","volume":"23","author":"Bruce","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312032273000_10.1.e004062.22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205207"},{"key":"2025090312032273000_10.1.e004062.23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.102053"},{"key":"2025090312032273000_10.1.e004062.24","unstructured":"Janssens H , Lopuha\u00e4 DE , Schaafstra A , et al . NHG Standaard Artritis. 2017."},{"key":"2025090312032273000_10.1.e004062.25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210602"},{"key":"2025090312032273000_10.1.e004062.26","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-019-0102-7","article-title":"Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States","volume":"4","author":"Ogdie","year":"2020","journal-title":"BMC Rheumatol"},{"key":"2025090312032273000_10.1.e004062.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201972"},{"key":"2025090312032273000_10.1.e004062.28","doi-asserted-by":"crossref","unstructured":"Fagni F , Motta F , Schett G , et al . Difficult-to-treat psoriatic arthritis: a conceptual approach. Arthritis Rheumatol December 18, 2023. doi:10.1002\/art.42780","DOI":"10.1002\/art.42780"},{"key":"2025090312032273000_10.1.e004062.29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205389"},{"key":"2025090312032273000_10.1.e004062.30","doi-asserted-by":"crossref","first-page":"103357","DOI":"10.1016\/j.autrev.2023.103357","article-title":"Effect of body mass index on treatment response of biologic\/targeted-synthetic Dmards in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. a systematic review","volume":"22","author":"Gialouri","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025090312032273000_10.1.e004062.31","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/acr.24593","article-title":"Depression and anxiety reduce the probability of achieving a state of sustained minimal disease activity in patients with psoriatic arthritis","volume":"74","author":"Wong","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312032273000_10.1.e004062.32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211284"},{"key":"2025090312032273000_10.1.e004062.33","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151491"},{"key":"2025090312032273000_10.1.e004062.34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41584-022-00810-7","article-title":"Sex- and gender-related differences in Psoriatic arthritis","volume":"18","author":"Tarannum","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2025090312032273000_10.1.e004062.35","doi-asserted-by":"publisher","DOI":"10.1186\/ar2580"},{"key":"2025090312032273000_10.1.e004062.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00578-2"},{"key":"2025090312032273000_10.1.e004062.37","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032482"},{"key":"2025090312032273000_10.1.e004062.38","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.184"},{"key":"2025090312032273000_10.1.e004062.39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence","volume":"182","author":"Korman","year":"2020","journal-title":"Br J Dermatol"},{"key":"2025090312032273000_10.1.e004062.40","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.723944","article-title":"Early origins of Psoriatic arthritis: clinical, genetic and molecular biomarkers of progression from psoriasis to Psoriatic arthritis","volume":"8","author":"Pennington","year":"2021","journal-title":"Front Med (Lausanne)"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-004062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:03:29Z","timestamp":1756926209000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-004062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2,27]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/rmdopen-2023-004062"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-004062","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}